We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $8.15B
1-Year Est. Return 20.12%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+20.12%
3 Year Est. Return
+59.68%
5 Year Est. Return
+57.89%
10 Year Est. Return
+205.42%
AUM
$5.96B
AUM Growth
+$2.07B
Cap. Flow
+$2B
Cap. Flow %
33.48%
Top 10 Hldgs %
30.72%
Holding
1,529
New
864
Increased
570
Reduced
53
Closed
13

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$95.8M
2
AAPL icon
Apple
AAPL
+$77.1M
3
MSFT icon
Microsoft
MSFT
+$70.4M
4
NVDA icon
NVIDIA
NVDA
+$50.7M
5
AMZN icon
Amazon
AMZN
+$42.9M

Sector Composition

Rank Sector Weight
1 Technology 12.62%
2 Financials 8.07%
3 Consumer Discretionary 4.51%
4 Healthcare 4.05%
5 Industrials 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBI icon
1101
Pitney Bowes
PBI
$2.42B
$296K 0.01%
49,807
+15,588
+46% +$74.4K
PCRX icon
1102
Pacira BioSciences
PCRX
$1.02B
$296K 0.01%
+10,402
New +$296K
THG icon
1103
Hanover Insurance
THG
$7.63B
$294K ﹤0.01%
+2,355
New +$306K
FORM icon
1104
FormFactor
FORM
$8.11B
$293K ﹤0.01%
+4,815
New +$251K
FPH icon
1105
Five Point Holdings
FPH
$379M
$293K ﹤0.01%
+100,000
New +$309K
VAW icon
1106
Vanguard Materials ETF
VAW
$3B
$293K ﹤0.01%
+1,530
New +$304K
IRWD icon
1107
Ironwood Pharmaceuticals
IRWD
$611M
$292K ﹤0.01%
+44,839
New +$317K
VERU icon
1108
Veru
VERU
$36.1M
$292K ﹤0.01%
33,205
+24,013
+261% +$278K
CMA
1109
DELISTED
Comerica
CMA
$292K ﹤0.01%
+5,737
New +$293K
TAK icon
1110
Takeda Pharmaceutical
TAK
$55.1B
$292K ﹤0.01%
+22,442
New +$297K
OLED icon
1111
Universal Display
OLED
$3.71B
$291K ﹤0.01%
+1,395
New +$245K
JCPB icon
1112
JPMorgan Core Plus Bond ETF
JCPB
$13.8B
$291K ﹤0.01%
+6,352
New +$292K
CG icon
1113
Carlyle Group
CG
$16.3B
$291K ﹤0.01%
+7,346
New +$317K
TRN icon
1114
Trinity Industries
TRN
$2.97B
$291K ﹤0.01%
9,940
+2,740
+38% +$79.8K
MMSI icon
1115
Merit Medical Systems
MMSI
$4.43B
$289K ﹤0.01%
+3,374
New +$265K
HIW icon
1116
Highwoods Properties
HIW
$3.71B
$288K ﹤0.01%
+10,919
New +$280K
DKS icon
1117
Dick's Sporting Goods
DKS
$18.4B
$288K ﹤0.01%
+1,402
New +$292K
KNG icon
1118
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.4B
$288K ﹤0.01%
+5,755
New +$298K
SCHE icon
1119
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$287K ﹤0.01%
10,799
-740
-6% -$19.3K
ESNT icon
1120
Essent Group
ESNT
$6.06B
$287K ﹤0.01%
+5,154
New +$287K
EPRT icon
1121
Essential Properties Realty Trust
EPRT
$6.99B
$287K ﹤0.01%
+10,453
New +$279K
SCCO icon
1122
Southern Copper
SCCO
$141B
$286K ﹤0.01%
+2,815
New +$300K
FELC icon
1123
Fidelity Enhanced Large Cap Core ETF
FELC
$7.83B
$286K ﹤0.01%
+9,330
New +$274K
KYN icon
1124
Kayne Anderson Energy Infrastructure Fund
KYN
$2.52B
$284K ﹤0.01%
+27,783
New +$275K
CPAY icon
1125
Corpay
CPAY
$24.2B
$284K ﹤0.01%
+1,065
New +$301K

Similar funds

Choreo LLC's Q2 2024 Portfolio in Review

As of Q2 2024, Choreo LLC held 1,529 positions worth $5.96B, up 53% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Choreo LLC deployed $2B of net new capital in Q2 2024, opening 864 new positions and adding to 570 existing holdings. Its largest new stake was Blackstone Mortgage Trust: 407,643 shares worth $6.98M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Small-Cap Value ETF, an estimated $6.41M trimmed.

  • Choreo LLC's largest Q2 2024 buy was Blackstone Mortgage Trust: 407,643 shares worth $6.98M.
  • Choreo LLC added most to Bank of America in Q2 2024, an estimated $95.8M increase.
  • Choreo LLC's biggest Q2 2024 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $6.41M.
  • Choreo LLC fully exited Fulton Financial in Q2 2024, selling an estimated $268K.
  • Choreo LLC's ten largest holdings make up 31% of its $5.96B portfolio in Q2 2024.
  • Choreo LLC opened 864 new positions and closed 13 in Q2 2024.
  • Choreo LLC's portfolio value rose 53% quarter-over-quarter to $5.96B.

Based on Choreo LLC's 13F filing for Q2 2024, filed 7 Aug 2024.